[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck. - Wikidata - awgldk - TriplyDB

[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck.

[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck.

http://www.wikidata.org/entity/Q46897615

about

Toxicity of MRI and CT contrast agents Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins Quantitative in vivo cell-surface receptor imaging in oncology: kinetic modeling and paired-agent principles from nuclear medicine and optical imaging Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery SPECT and PET imaging of angiogenesis and arteriogenesis in pre-clinical models of myocardial ischemia and peripheral vascular disease Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment Translational imaging endpoints to predict treatment response to novel targeted anticancer agents.Preclinical molecular imaging of tumor angiogenesis.18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression.Progress on the diagnosis and evaluation of brain tumors.Application of (68)Ga-PRGD2 PET/CT for αvβ3-integrin imaging of myocardial infarction and stroke.An integrated MR/PET system: prospective applications.Peptide-based probes for targeted molecular imaging.Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography.PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.RGD-Binding Integrins in Head and Neck Cancers.Peptides and peptide hormones for molecular imaging and disease diagnosis 2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics Importance of quantification for the analysis of PET data in oncology: review of current methods and trends for the future.Non-invasive imaging of angiogenesis in head and neck squamous cell carcinoma FITC-conjugated cyclic RGD peptides as fluorescent probes for staining integrin αvβ3/αvβ5 in tumor tissues.Synthesis and evaluation of new iRGD peptide analogs for tumor optical imaging.PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide.Positron emission tomography imaging of cancer biology: current status and future prospects Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT Phase I/II trial of cilengitide with cetuximab, cisplatin and 5-fluorouracil in recurrent and/or metastatic squamous cell cancer of the head and neck: findings of the phase I part.An exploratory study on 99mTc-RGD-BBN peptide scintimammography in the assessment of breast malignant lesions compared to 99mTc-3P4-RGD2 Image-derived input function for brain PET studies: many challenges and few opportunities.The next generation of positron emission tomography radiopharmaceuticals in oncology.PET Imaging of Integrin Positive Tumors Using F Labeled Knottin Peptides.Pilot Prospective Evaluation of (18)F-Alfatide II for Detection of Skeletal Metastases Imaging key biomarkers of tumor angiogenesis Stroma targeting nuclear imaging and radiopharmaceuticals.(18)F-Alfatide II PET/CT in healthy human volunteers and patients with brain metastases.Positron emission tomography tracers for imaging angiogenesis.Optical imaging of integrin alphavbeta3 expression with near-infrared fluorescent RGD dimer with tetra(ethylene glycol) linkers.First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.

P2860

Q22306013-FBB45F95-07F8-487F-BAFB-E568BFF2E3AE Q26771417-80926BB7-6B32-4BE2-ABF6-D85E660AC864 Q26801806-A31A92E2-63E6-4E38-B698-93392D309CC1 Q27023605-DC7DE788-11AC-42E1-A618-C994E2DD1B58 Q27024850-BF4A2E54-0B92-46CF-81CE-0B6951D2E4AE Q28066121-22C00A7D-A191-4CA3-A5CD-DECD8EF2B19A Q28072021-BB987959-7901-4333-9CEF-767162ADAFAC Q30454718-A25AE31A-1F19-4849-8C21-36AACAAA1084 Q30465097-D5BDD98D-7CD6-490E-8732-01BE95C1C547 Q30475818-D6CAFDCA-9CC5-4DA1-ACEA-E9D3D4013ADF Q30497615-D03B9A75-5051-4329-B273-82588BEB37F0 Q30714285-584DFDA7-D171-4DDD-AA1B-7081A8E4BEDE Q30832796-19610D42-32AA-43D0-8538-2CE9AA700C00 Q33367167-3AA2B708-2ABA-4CE1-AA48-DB2CBC36AD85 Q33526620-488973D7-9C4F-44FA-A18C-7CA3690892AC Q33574585-521B8572-B5CE-46BD-8CC8-A4C5EFC5F076 Q33578187-6CBAF035-9BBA-437C-BC57-A15936292715 Q33832735-378C98A3-13DA-4058-8A2F-6519A88E34CA Q33846924-ECFD8642-0465-4FA2-B1F5-D4D89B157132 Q33925952-98EBA98B-C613-4967-9295-B868FE482BC3 Q33993075-56F66526-57C3-467C-9062-55F55E3B4086 Q34029591-DB0F6548-2437-40AA-958C-66DED257A22C Q34556242-9A6F5751-57F2-40CC-9328-AE0CB7714873 Q34572049-4CDF654D-FBEC-456E-84F1-347E548D3362 Q34677001-4A75084D-F0E9-4D3E-ADA1-E30C7FC81994 Q34697688-AC66EE6D-8123-4B29-BE4D-446BF1B20606 Q34912643-A245B313-ED63-46B1-A7FD-7AD02E4E9B35 Q35034608-3FDF007A-C99D-42AE-B2D9-B2F67EC948B0 Q35304493-F6DB46D2-DF94-4DFF-ADDA-4FBC27747A61 Q35524029-570B5B79-DA90-45D9-87E1-018929631D74 Q35525690-46B6A9A3-6B7E-4B36-852D-AD8C785F0F9C Q35641937-9E525877-C2AC-43DE-BE49-34A147919A62 Q35868880-CFDDD701-B397-4DB8-9ACE-4E31FF8BF9AD Q35999557-1CC55FB0-FEDB-4237-8A70-0FED13361D17 Q35999606-6E127D58-FEFF-4352-BB5A-3456AF00DCA7 Q36225629-DFCF9285-003F-454D-A942-0143EDDF29E9 Q36777285-45520435-4B7A-49DC-A302-C98B36E49479 Q36777406-1BC5C98B-F8B7-40C1-8FAF-39A6D22357AE Q36931413-501FAE9A-C278-4CEA-BBC7-58FA21D373C5 Q37172093-291DAAAB-8C3F-4E01-8751-7627CF0AD563

P2860

[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck.

http://www.wikidata.org/entity/Q46897615

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

[18F]galacto-RGD positron emis ...... arcinoma of the head and neck.

@en

[18F]galacto-RGD positron emis ...... arcinoma of the head and neck.

@nl

type

label

[18F]galacto-RGD positron emis ...... arcinoma of the head and neck.

@en

[18F]galacto-RGD positron emis ...... arcinoma of the head and neck.

@nl

prefLabel

[18F]galacto-RGD positron emis ...... arcinoma of the head and neck.

@en

[18F]galacto-RGD positron emis ...... arcinoma of the head and neck.

@nl

P1433

Q46897615-1E471AAF-931E-4828-BF9E-5632967B7646

P1476

Q46897615-D05FD587-A24B-4BBA-96D4-4085E06C82A4

P2093

Q46897615-1EE04815-C16F-4D82-AEF1-12D53D69F547

Q46897615-2708B591-A9DC-47C0-910E-8B8476BC394C

Q46897615-6A416DF1-6644-44CC-9A66-524C64AB31D6

Q46897615-7F491FA1-C5B9-4A36-98E4-2200B19A0398

Q46897615-A87780D9-A333-44FC-9BBE-7B3BB28552ED

Q46897615-B0DFD599-19BC-44B7-A566-DF8A3335F206

Q46897615-D56E8891-92FF-402A-8496-4C495A72C759

Q46897615-D7D406B2-CD7A-4DAE-834B-3DCE682997CD

Q46897615-DC39FEED-2316-4D93-9AB4-44B3F5F0049A

P304

Q46897615-A64F6995-0A19-43CA-9AF2-DC14CA7B6AD4

P31

Q46897615-69E0D194-027C-4CAD-A780-57E3302046B5

P356

Q46897615-D5440FA1-7498-4BF6-8CFC-3EE1C7FFB055

P407

Q46897615-BA48CF2D-542D-4DCC-96B3-3EAA90DE8E9C

P433

Q46897615-1655F8AC-2FE6-405C-B323-0F3FBB513CBD

P478

Q46897615-EEA2E2A2-7AF0-4E9B-913E-6FF2EF86AA56

P50

Q46897615-01FB0D25-6B6B-453C-8481-2BD43F767D35

P577

Q46897615-CC2E7CAD-2270-4F93-9608-1323EFE1ADB8

P5875

Q46897615-09BE8EAA-6855-492A-B1BB-A5E1DC1725A4

P698

Q46897615-CF96ED23-E85A-4557-B1A9-AE10F94DD43F

P921

Q46897615-37D394C6-E38F-4443-A7B6-95302EAAF00A

P356

1078-0432.CCR-07-0528

P1433

Clinical Cancer Research

P1476

[18F]galacto-RGD positron emis ...... arcinoma of the head and neck.

@en

P2093

Ambros J Beer

http://www.w3.org/2001/XMLSchema#string

Anca-Ligia Grosu

http://www.w3.org/2001/XMLSchema#string

Andreas Kolk

http://www.w3.org/2001/XMLSchema#string

Hans-Jürgen Wester

http://www.w3.org/2001/XMLSchema#string

Isabelle Stangier

http://www.w3.org/2001/XMLSchema#string

Janette Carlsen

http://www.w3.org/2001/XMLSchema#string

Mario Sarbia

http://www.w3.org/2001/XMLSchema#string

Petra Watzlowik

http://www.w3.org/2001/XMLSchema#string

Roland Haubner

http://www.w3.org/2001/XMLSchema#string

P304

6610-6616

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-07-0528

http://www.w3.org/2001/XMLSchema#string

P407

P433

22 Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Markus Schwaiger

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5839831

http://www.w3.org/2001/XMLSchema#string

P698

18006761

http://www.w3.org/2001/XMLSchema#string

P921